Barchas Isaac

Track

Insider profile

Barchas Isaac's trades of Immunome Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Immunome Inc (IMNM)
Transaction date
Planned sale
Price
215.58
Quantity 5,832 -26.2%
Value US$1,807,502
US Immunome Inc (IMNM)
Transaction date
Proposed sale
Price
176.69
Quantity 63,978
Value US$717,416
US Immunome Inc (IMNM)
Transaction date
Planned sale
Price
89.46
Quantity 61,029 -22.2%
Value US$3,487,491
US Immunome Inc (IMNM)
Transaction date
Planned sale
Price
26.07
Quantity 10,125 -14.0%
Value US$263,959
US Immunome Inc (IMNM)
Transaction date
Planned sale
Price
26.06
Quantity 15,248 -17.4%
Value US$397,363
US Immunome Inc (IMNM)
Transaction date
Planned sale
Price
26.06
Quantity 20,840 -19.2%
Value US$543,090
US Immunome Inc (IMNM)
Transaction date
Planned sale
Price
24.20
Quantity 16,906 -13.5%
Value US$409,125
US Immunome Inc (IMNM)
Transaction date
Planned sale
Price
24.11
Quantity 83,094 -39.9%
Value US$2,003,396
US Immunome Inc (IMNM)
Transaction date
Planned sale
Price
23.33
Quantity 24,335 -10.5%
Value US$567,736
US Immunome Inc (IMNM)
Transaction date
Planned sale
Price
22.35
Quantity 75,665 -24.5%
Value US$1,691,113
US Immunome Inc (IMNM)
Transaction date
Planned sale
Price
21.12
Quantity 101,050 -24.7%
Value US$2,134,176
US Immunome Inc (IMNM)
Transaction date
Planned sale
Price
22.34
Quantity 11,251 -0.6%
Value US$251,347
US Immunome Inc (IMNM)
Transaction date
Planned sale
Price
21.72
Quantity 371,949 -15.4%
Value US$8,078,732
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-12 2026-08-12
US Immunome Inc (IMNM)
PlS Planned sale
5,832 -26.2%
215.58
US$1,807,502 		5,832 -26.2% 215.58 US$1,807,502
2026-08-12 2026-08-12
US Immunome Inc (IMNM)
PrS Proposed sale
63,978
176.69
US$717,416 		63,978 176.69 US$717,416
2026-08-12 2026-08-11
US Immunome Inc (IMNM)
PlS Planned sale
61,029 -22.2%
89.46
US$3,487,491 		61,029 -22.2% 89.46 US$3,487,491
2026-08-12 2026-08-10
US Immunome Inc (IMNM)
PlS Planned sale
10,125 -14.0%
26.07
US$263,959 		10,125 -14.0% 26.07 US$263,959
2026-08-10 2026-08-07
US Immunome Inc (IMNM)
PlS Planned sale
15,248 -17.4%
26.06
US$397,363 		15,248 -17.4% 26.06 US$397,363
2026-08-10 2026-08-06
US Immunome Inc (IMNM)
PlS Planned sale
20,840 -19.2%
26.06
US$543,090 		20,840 -19.2% 26.06 US$543,090
2026-07-07 2026-07-07
US Immunome Inc (IMNM)
PlS Planned sale
16,906 -13.5%
24.20
US$409,125 		16,906 -13.5% 24.20 US$409,125
2026-07-07 2026-07-06
US Immunome Inc (IMNM)
PlS Planned sale
83,094 -39.9%
24.11
US$2,003,396 		83,094 -39.9% 24.11 US$2,003,396
2026-07-02 2026-07-02
US Immunome Inc (IMNM)
PlS Planned sale
24,335 -10.5%
23.33
US$567,736 		24,335 -10.5% 23.33 US$567,736
2026-07-02 2026-07-02
US Immunome Inc (IMNM)
PlS Planned sale
75,665 -24.5%
22.35
US$1,691,113 		75,665 -24.5% 22.35 US$1,691,113
2026-07-02 2026-06-30
US Immunome Inc (IMNM)
PlS Planned sale
101,050 -24.7%
21.12
US$2,134,176 		101,050 -24.7% 21.12 US$2,134,176
2025-12-23 2025-12-22
US Immunome Inc (IMNM)
PlS Planned sale
11,251 -0.6%
22.34
US$251,347 		11,251 -0.6% 22.34 US$251,347
2025-12-23 2025-12-22
US Immunome Inc (IMNM)
PlS Planned sale
371,949 -15.4%
21.72
US$8,078,732 		371,949 -15.4% 21.72 US$8,078,732